ZOETIS INC ZOETIS ORD SHS CLASS (0M3Q.L) Financials
0M3Q.L Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 14.1 billion | 9.0 billion |
| 2023-06-30 | 13.7 billion | 9.1 billion |
| 2023-03-31 | 13.8 billion | 9.3 billion |
0M3Q.L Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 579.0 million | 17.0 million |
| 2023-06-30 | 17.0 million | 17.0 million |
| 2023-03-31 | 326.0 million | 9.0 million |
0M3Q.L Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 525.0 million |
| 2023-09-30 | 596.0 million |
| 2023-06-30 | 671.0 million |
| 2023-03-31 | 552.0 million |
0M3Q.L Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-09-30 | 1.8 billion | - | - |
| 2023-06-30 | 1.7 billion | - | - |
| 2023-03-31 | 2.1 billion | - | - |
0M3Q.L Shares Outstanding
0M3Q.L Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-09-30 | 145.0 million | 152.0 million | - | - |
| 2023-06-30 | 166.0 million | 146.0 million | - | - |
| 2023-03-31 | 223.0 million | 142.0 million | - | - |
0M3Q.L Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | - | - |
| 2023-09-30 | 2.2 billion | 638.0 million |
| 2023-06-30 | 2.2 billion | 607.0 million |
| 2023-03-31 | 2.0 billion | 588.0 million |
0M3Q.L
Price: $174.47
Dividend Yield: 0.01%
Forward Dividend Yield: 0.99%
Payout Ratio: 39.64%
Dividend Per Share: 1.73 USD
Earnings Per Share: 4.36 USD
P/E Ratio: 45.58
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 815.7 million
Average Dividend Frequency: 4
Years Paying Dividends: 7
DGR3: 18.80%
DGR5: 18.60%